Rivaroxaban EP Impurity D CAS 1365267-35-1
| CAS No. | 1365267-35-1 |
| Molecular Formula | C29H32N6O9 |
| Molecular Weight | 608.60 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
CATO supplies Rivaroxaban EP Impurity D (CAS 1365267-35-1), a pharmacopoeial impurity reference standard (molecular formula C29H32N6O9, MW 608.60 g/mol) used for the identification and quantification of trace impurities in APIs.
The molecular framework of Rivaroxaban EP Impurity D (C29H32N6O9) is characterized by a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Rivaroxaban EP Impurity D under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C29H32N6O9 |
| Molecular Weight | 608.60 g/mol |
| Purity | >95% |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 17.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1991 |
| Nitrogen Atoms | 6 |
Related Rivaroxaban Standards
- Rivaroxaban Impurity N7 (CAS 2459945-88-9)
- Rivaroxaban Impurity 181 (CAS CATO-C4X-1090181)
- Rivaroxaban impurity 195 (CAS CATO-C4X-1090195)
- Rivaroxaban Impurity 23 (CAS 1807455-76-0)
- Rivaroxaban phthalimido ethyl ester analog (CAS 2206826-56-2)
- Rivaroxaban Impurity 171 (CAS CATO-C4X-1090171)
- Rivaroxaban Impurity 185 (CAS CATO-C4X-1090185)
- Rivaroxaban Impurity 56 (CAS 1643354-27-1)
Recommended Standards
- N,N-[1,4-Phenylenebis[(1-methylethylidene)-4,1-phenylene]]bis[1,1,1]-trifluoro-methanesulfonamide (CAS 329317-98-8)
- Netupitant Impurity 54 (CAS CATO-C4X-122354)
- (2R,3R,4R,5R)-5-((Benzoyloxy)methyl)-2-(2,6-diamino-9H-purin-9-yl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate (CAS 1412427-05-4)
- Netupitant Impurity 57 (CAS CATO-C4X-122357)
- Cefotaxime Impurity 28 (CAS CATO-C4X-120128)
- Levothyroxine EP Impurity A (CAS 6893-02-3)
- Olopatadine Impurity 18 (CAS 55453-90-2)
- 5-(5-Fluoro-2-hydroxybenzoyl)-1-(3-methoxypropyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile (CAS 743444-86-2)
- Ethyl 2-amino-5-(tert-butyl)-1H-pyrrole-3-carboxylate (CAS 785806-32-8)
- (3,3,3-trifluoro-2-methyl-propyl) trifluoromethanesulfonate (CAS 2089241-92-7)
- 5-Bromo-N-morpholinothiophene-2-carboxamide (CAS 777879-62-6)
- 2,3,6,7-Tetramethoxyanthracene-9,10-dione (CAS 5629-55-0)
- (R)-2-Cyclohexylpiperazine (CAS 1240584-63-7)
- Peptide Fmoc-Thi-Thi-OH (CAS CATO-CPTD788552)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com